Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

MBX-2982

🥰Excellent
Catalog No. T1793Cas No. 1037792-44-1

MBX-2982 is a selective, orally available GPR119 agonist used in the treatment of diabetes.

MBX-2982

MBX-2982

🥰Excellent
Purity: 99.96%
Catalog No. T1793Cas No. 1037792-44-1
MBX-2982 is a selective, orally available GPR119 agonist used in the treatment of diabetes.
Pack SizePriceAvailabilityQuantity
1 mg43 €In Stock
2 mg62 €In Stock
5 mg103 €In Stock
10 mg177 €In Stock
25 mg346 €In Stock
50 mg531 €In Stock
100 mg746 €In Stock
1 mL x 10 mM (in DMSO)113 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "MBX-2982"

Select Batch
Purity:99.96%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
MBX-2982 is a selective, orally available GPR119 agonist used in the treatment of diabetes.
In vitro
In cells that underwent chronic incubation and subsequent washout with MBX-2982 (1 μM), a significant rise in cAMP levels was observed, as measured by IBMX inclusion, when compared to control cells, indicating enhanced accumulation despite thorough washing to eliminate any excess agonist (P<0.01; ANOVA; n=3-6). Similarly, AR-231,453 elicited prolonged responses within a comparable concentration range to acute exposure, showing a modest increase in potency (1.82-fold difference), with pEC50 values of 8.67±0.11 for sustained exposure and 8.93±0.17 for acute. Furthermore, MBX-2982 displayed a substantial yet smaller alteration in concentration response curves during sustained versus acute exposure (57.54-fold difference), with pEC50 values of 7.03±0.13 for sustained and 8.79±0.12 for acute treatment[1].
In vivo
To determine the physiological relevance of findings in GLUTag and primary intestinal cells, C57BL/6 mice were administered 10 mg/kg of the GPR119 agonist MBX-2982, without co-administration of a DPP-IV inhibitor, to assess the direct effects of GPR119 activation. However, a DPP-IV inhibitor was utilized to maintain active GLP-1 levels in blood samples. Results showed elevated plasma GLP-1 levels in mice treated with MBX-2982, even in the absence of a glucose load, demonstrating that GPR119-induced GLP-1 secretion does not require glucose (2).
Kinase Assay
HEK-GPR119 cells are transfected with GloSensor 22F plasmid and used for dynamic cAMP measurements 24-30 h later. Cell suspensions are made by dislodging the cells using PBS wash and Accutase treatment followed by resuspension in culture media. Cells are then washed twice by pelleting through centrifugation (300 g, 5 min) and resuspension in assay buffer (Hank's Balanced Salt Solution supplemented with 20 mM HEPES and 0.01% fatty acid free BSA, pH 7.4). Cells are then counted and diluted to 600,000 cells/mL in buffer, before GloSensor cAMP reagent is added (2% v/v) and equilibrated with the cells for 2 h at 20°C with periodic mixing. 50 μl/well of cells are added to white-bottomed 384 well plates (30,000 cells/well) in triplicate and baseline luminescence is measuring using an Envision plate-reader. 5 μL of MBX-2982 (serially diluted in DMSO and then diluted 1:100 in assay buffer to obtain ×10 concentrated solution) is manually added to the assay wells to achieve the stated final concentration. Plates are incubated at 20°C with luminescence read at regular intervals to detect dynamic cAMP changes over time within the same wells. cAMP responses at each time-point are expressed as fold over control (vehicle-treated cells)[1].
Cell Research
MBX-2982 is serially diluted in DMSO and then diluted 1:100 in assay buffer to obtain ×10 concentrated solutionis[1]. HEK-GPR119 cells are grown to confluency in flasks, and cell suspensions are made by dislodging cells using PBS wash and accutase treatment followed by resuspension in culture media. Cells are then washed twice by pelleting through centrifugation (227 g, 7 min, 20°C) and resuspension in warm assay buffer (Hank's Balanced Salt Solution supplemented with 20 mM HEPES and 0.01% fatty acid free BSA, pH 7.4), with a 5 min incubation at 37°C after the second wash. Cells are then counted and diluted to 200,000 cells/mL in warm assay buffer[1].
Chemical Properties
Molecular Weight448.54
FormulaC22H24N8OS
Cas No.1037792-44-1
SmilesCCc1cnc(nc1)N1CCC(CC1)c1ncc(COc2ccc(cc2)-n2cnnn2)s1
Relative Density.1.42 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (111.47 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2295 mL11.1473 mL22.2946 mL111.4728 mL
5 mM0.4459 mL2.2295 mL4.4589 mL22.2946 mL
10 mM0.2229 mL1.1147 mL2.2295 mL11.1473 mL
20 mM0.1115 mL0.5574 mL1.1147 mL5.5736 mL
50 mM0.0446 mL0.2229 mL0.4459 mL2.2295 mL
100 mM0.0223 mL0.1115 mL0.2229 mL1.1147 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy MBX-2982 | purchase MBX-2982 | MBX-2982 cost | order MBX-2982 | MBX-2982 chemical structure | MBX-2982 in vivo | MBX-2982 in vitro | MBX-2982 formula | MBX-2982 molecular weight